Skip to search formSkip to main contentSkip to account menu

R 126638

Known as: R-126638, R126638 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

pramiconazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections: an exploratory phase IIa trial.
Pramiconazole (R126638) is a novel azole with potent antifungal activity against yeasts, dermatophytes and many other fungal… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
The activity of R126638, a new triazole antifungal, as assessed by corneofungimetry
2005
2005
Effect of a single dose of R126638 in seborrheic dermatitis
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2004
2004
In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638
ABSTRACT R126638 is a new triazole agent with potent antifungal activity in vitro against various dermatophytes, Candida spp… 
2004
2004
In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R 126638
In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638 F. Odds, J. Ausma,* F. Van Gerven, F. Woestenborghs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)